Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209819

Expand all

SUBLOCADE (BUPRENORPHINE)
100MG/0.5ML (100MG/0.5ML)
Marketing Status: Prescription
Active Ingredient: BUPRENORPHINE
Proprietary Name: SUBLOCADE
Dosage Form; Route of Administration: SOLUTION, EXTENDED RELEASE; SUBCUTANEOUS
Strength: 100MG/0.5ML (100MG/0.5ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209819
Product Number: 001
Approval Date: Nov 30, 2017
Applicant Holder Full Name: INDIVIOR INC
Marketing Status:  Prescription
Patent and Exclusivity Information
SUBLOCADE (BUPRENORPHINE)
300MG/1.5ML (200MG/ML)
Marketing Status: Prescription
Active Ingredient: BUPRENORPHINE
Proprietary Name: SUBLOCADE
Dosage Form; Route of Administration: SOLUTION, EXTENDED RELEASE; SUBCUTANEOUS
Strength: 300MG/1.5ML (200MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209819
Product Number: 002
Approval Date: Nov 30, 2017
Applicant Holder Full Name: INDIVIOR INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English